{"url":"https://lda.senate.gov/api/v1/filings/2eb8a3b3-d2fe-4bc7-a6ca-50383205a3d2/","filing_uuid":"2eb8a3b3-d2fe-4bc7-a6ca-50383205a3d2","filing_type":"3A","filing_type_display":"3rd Quarter - Amendment","filing_year":2018,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2eb8a3b3-d2fe-4bc7-a6ca-50383205a3d2/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Romano Romani","dt_posted":"2019-01-16T16:41:00.050000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"517 C Street, NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":30792,"url":"https://lda.senate.gov/api/v1/registrants/30792/","house_registrant_id":30115,"name":"PARRY, ROMANI, DECONCINI & SYMMS","description":"Consulting","address_1":"517 C Street NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROMANO ROMANI","contact_telephone":"+1 202-547-4000","dt_updated":"2026-04-23T11:31:32.295882-04:00"},"client":{"id":136215,"url":"https://lda.senate.gov/api/v1/clients/136215/","client_id":1004734,"name":"ROCK & ASSOCIATES","general_description":"Lobbying and government relations.","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-06-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13252,"prefix":null,"prefix_display":null,"first_name":"ROMANO","nickname":null,"middle_name":null,"last_name":"ROMANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5895,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"SYMMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":23447,"prefix":"mr","prefix_display":"MR.","first_name":"THADDEUS","nickname":null,"middle_name":"E","last_name":"STROM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations to fund the FDA implementation of compounding pharmacy regulations: H.R. 1625, Consolidated Appropriations Act 2018","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13252,"prefix":null,"prefix_display":null,"first_name":"ROMANO","nickname":null,"middle_name":null,"last_name":"ROMANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5895,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"SYMMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":23447,"prefix":"mr","prefix_display":"MR.","first_name":"THADDEUS","nickname":null,"middle_name":"E","last_name":"STROM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13252,"prefix":null,"prefix_display":null,"first_name":"ROMANO","nickname":null,"middle_name":null,"last_name":"ROMANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5895,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"SYMMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":23447,"prefix":"mr","prefix_display":"MR.","first_name":"THADDEUS","nickname":null,"middle_name":"E","last_name":"STROM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}